Medicine News and Research

RSS

Johnson & Johnson begins Phase 1 trial of preventive Ebola vaccine program

Johnson & Johnson today announced the start of a Phase 1, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen Pharmaceutical Companies.

6 Jan 2015

Chronic hypertension increases glaucoma risk

A new study published in Investigative Ophthalmology & Visual Science has found that chronic (long term) hypertension increases a person's susceptibility to glaucoma. These results suggest that doctors should consider a patient's blood pressure levels in managing the potentially blinding eye disorder.

6 Jan 2015

Johns Hopkins scientists use genome editing technology to alter human stem cells

A powerful “genome editing” technology known as CRISPR has been used by researchers since 2012 to trim, disrupt, replace or add to sequences of an organism’s DNA.

6 Jan 2015

Men's eating habits associated with availability of healthy food outlets around home

Canadian men's eating habits are associated with the availability of healthy food sources in their residential neighbourhood but women's are not, according to researchers at the University of Montreal and its affiliated CHUM hospital.

6 Jan 2015

ANSTO launches nuclear medicine program to improve diagnosis, treatment of cancer and heart disease

You can’t see it, hear it or smell it, and it’s constantly changing: but despite that, Australia’s nuclear scientists have figured out how to more accurately measure the unit of activity for radionuclides, the Becquerel (Bq).

6 Jan 2015

Quanta obtains CE mark for portable, cartridge-based haemodialysis system

Quanta Fluid Solutions Ltd, a pioneering developer of advanced haemodialysis systems, announces it has received the CE mark for SC+, its portable, cartridge-based haemodialysis system.

6 Jan 2015

Oncoceutics, MD Anderson partner to develop novel anti-cancer drug

Oncoceutics Inc. and The University of Texas MD Anderson Cancer Center today announced the initiation of a strategic alliance and research collaboration agreement for the clinical development of ONC201, a novel anti-cancer drug.

5 Jan 2015

TxCell announces further enhancement to development of Ovasave for IBD treatment

Paulsen Foundation to provide specialist management and scientific and development expertise that is dedicated to advanced therapies, i.e. cellular and gene therapies. This new class of highly promising biological therapies includes TxCell’s Ovasave.

5 Jan 2015

Saatchi Bill: an interview with Dr. David Collingridge, Editor-in-Chief, The Lancet Oncology

The intention of the Medical Innovation Bill is to encourage and support doctors to explore new medicines for their patients when they believe existing options are no longer achieving good outcomes.

4 Jan 2015

Fat cells below skin help protect from bacteria, say researchers

When it comes to skin infections, a healthy and robust immune response may depend greatly upon what lies beneath. In a new paper published in the January 2, 2015 issue of Science, researchers at the University of California, San Diego School of Medicine report the surprising discovery that fat cells below the skin help protect us from bacteria.

2 Jan 2015

Johns Hopkins scientists create statistical model to measure proportion of cancer incidence

Scientists from the Johns Hopkins Kimmel Cancer Center have created a statistical model that measures the proportion of cancer incidence, across many tissue types, caused mainly by random mutations that occur when stem cells divide.

2 Jan 2015

Additional products seized from Calgary stores contain undeclared drug ingredients

Further to its recent Advisory, Health Canada has identified additional products seized from two Samson's Supplements stores in Calgary that pose a risk to health.

2 Jan 2015

UT Southwestern researchers target cells' biological clock to kill cancer cells, shrink tumor growth

Cell biologists at UT Southwestern Medical Center have targeted telomeres with a small molecule called 6-thiodG that takes advantage of the cell's 'biological clock' to kill cancer cells and shrink tumor growth.

2 Jan 2015

Mimedx receives subpoena from Office of Inspector General, HHS

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that it has received a subpoena from the Office of Inspector General ("OIG") of the Department of Health and Human Services ("HHS") in connection with a civil investigation into matters primarily related to the Company's sales and marketing activities.

2 Jan 2015

Breast cancer risk for women with atypical hyperplasia greater than previously thought, study finds

Women with atypical hyperplasia of the breast have a higher risk of developing breast cancer than previously thought, a Mayo Clinic study has found. Results of the study appear in a special report on breast cancer in the New England Journal of Medicine.

2 Jan 2015

Loyola to be included in "Guinness World Records" 2015 edition for neonatal care

Loyola University Medical Center will be included in the "Guinness World Records" 2015 edition for caring for the world's smallest baby.

2 Jan 2015

Top cancer research and clinical developments at Dana-Farber Cancer Institute in 2014

Immunotherapy, genomic profiling, and investigating game-changing drug therapies topped the list of most important cancer research and clinical developments at Dana-Farber Cancer Institute in 2014.

1 Jan 2015

Cardiac arrest associated with high mortality even in the world of Star Trek

The Star Trek universe is one of the most popular pieces of science fiction entertainment. Lots of the technologies seen in the TV and cinema episodes featuring Captain Kirk, Mr Spock or Captain Picard were once regarded as futuristic, but have now become reality - with examples including wireless communication or portable computers. In a recent study by the University Department of Emergency Medicine at the MedUni Vienna, the make-believe future of the human race depicted in this series has been used to investigate the frequency and mortality of cardiac arrests in the 24th century.

1 Jan 2015

MiMedx pleased with FDA Draft Guidance on Minimal Manipulation of HCT/Ps

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, commented on the Draft Guidance for Industry on Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products ("HCT/Ps") that the Food and Drug Administration ("FDA") published for comment on December 23, 2014.

31 Dec 2014

Combination of bedaquiline and verapamil reduces side effects, improves outcomes for TB patients

While an effective treatment is available for combating multidrug-resistant tuberculosis, it carries serious side effects for patients.

31 Dec 2014

Medicine News and Research

Johnson & Johnson begins Phase 1 trial of preventive Ebola vaccine program

Chronic hypertension increases glaucoma risk

Johns Hopkins scientists use genome editing technology to alter human stem cells

Men's eating habits associated with availability of healthy food outlets around home

ANSTO launches nuclear medicine program to improve diagnosis, treatment of cancer and heart disease

Quanta obtains CE mark for portable, cartridge-based haemodialysis system

Oncoceutics, MD Anderson partner to develop novel anti-cancer drug

TxCell announces further enhancement to development of Ovasave for IBD treatment

Saatchi Bill: an interview with Dr. David Collingridge, Editor-in-Chief, The Lancet Oncology

Fat cells below skin help protect from bacteria, say researchers

Johns Hopkins scientists create statistical model to measure proportion of cancer incidence

Additional products seized from Calgary stores contain undeclared drug ingredients

UT Southwestern researchers target cells' biological clock to kill cancer cells, shrink tumor growth

Mimedx receives subpoena from Office of Inspector General, HHS

Breast cancer risk for women with atypical hyperplasia greater than previously thought, study finds

Loyola to be included in "Guinness World Records" 2015 edition for neonatal care

Top cancer research and clinical developments at Dana-Farber Cancer Institute in 2014

Cardiac arrest associated with high mortality even in the world of Star Trek

MiMedx pleased with FDA Draft Guidance on Minimal Manipulation of HCT/Ps

Combination of bedaquiline and verapamil reduces side effects, improves outcomes for TB patients

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News